Bawang, Aya Azkiyyah B.

HRN: 23-76-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2024
AMPICILLIN 250MG (VIAL)
02/25/2024
03/02/2024
IV
155mg
Q6h
PCAP C
Waiting Final Action 
02/25/2024
AMPICILLIN 500MG (VIAL)
02/25/2024
03/03/2024
IV
310 Mg
Q 6 Hours
PCAP-C (dose Increased To 200 MkDay)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: